Japan Tissue Engineering Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	2,259	1,723	1,648	1,613	1,712	1,535
Other Revenue	-	732	866	419	391	722
Revenue	2,259	2,455	2,514	2,032	2,103	2,257
Revenue Growth (YoY)	-7.23%	-2.35%	23.72%	-3.38%	-6.82%	-2.25%
Cost of Revenue	912.11	944	823	896	848	1,101
Gross Profit	1,347	1,511	1,691	1,136	1,255	1,156
Selling, General & Admin	1,212	1,147	1,057	1,221	1,123	1,084
Research & Development	506.73	506	407	573	561	468
Other Operating Expenses	55.97	55	59	49	52	52
Operating Expenses	1,816	1,749	1,546	1,864	1,753	1,623
Operating Income	-469.65	-238	145	-728	-498	-467
Interest & Investment Income	9.22	2	-	1	2	3
Currency Exchange Gain (Loss)	-0.46	-	-	-1	-	-
Other Non Operating Income (Expenses)	3.72	1	1	2	3	1
EBT Excluding Unusual Items	-457.17	-235	146	-726	-493	-463
Gain (Loss) on Sale of Assets	-	-	-	-	-1	-
Asset Writedown	-0.12	-10	-130	-	-	-
Other Unusual Items	-	10	130	-	-	-
Pretax Income	-457.29	-235	146	-726	-494	-463
Income Tax Expense	4.17	20	3	3	3	3
Net Income	-461.45	-255	143	-729	-497	-466
Net Income to Common	-461.45	-255	143	-729	-497	-466
Shares Outstanding (Basic)	41	41	41	41	41	41
Shares Outstanding (Diluted)	41	41	41	41	41	41
Shares Change (YoY)	0.00%	-	-	-	-	-
EPS (Basic)	-11.36	-6.28	3.52	-17.95	-12.24	-11.48
EPS (Diluted)	-11.36	-6.28	3.52	-17.95	-12.24	-11.48
Free Cash Flow	-	-224	78	-771	-328	-461
Free Cash Flow Per Share	-	-5.52	1.92	-18.98	-8.08	-11.35
Gross Margin	59.62%	61.55%	67.26%	55.91%	59.68%	51.22%
Operating Margin	-20.79%	-9.70%	5.77%	-35.83%	-23.68%	-20.69%
Profit Margin	-20.43%	-10.39%	5.69%	-35.88%	-23.63%	-20.65%
Free Cash Flow Margin	-	-9.12%	3.10%	-37.94%	-15.60%	-20.42%
EBITDA	-	-80	279	-597	-374	-339
EBITDA Margin	-	-3.26%	11.10%	-29.38%	-17.78%	-15.02%
D&A For EBITDA	176	158	134	131	124	128
EBIT	-469.65	-238	145	-728	-498	-467
EBIT Margin	-20.79%	-9.69%	5.77%	-35.83%	-23.68%	-20.69%
Effective Tax Rate	-	-	2.05%	-	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.